VOLITION, NCT05917509: A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy |
|
|
| Active, not recruiting | 3 | 171 | Europe, Canada, US, RoW | DTG/3TC, Dovato, Cabotegravir (CAB) LA, Vocabria, Rilpivirine (RPV) LA, Rekambys | ViiV Healthcare, GlaxoSmithKline, PPD | HIV Infections | 08/25 | 08/26 | | |
